MANCHESTER, England--(BUSINESS WIRE)--Synexus® can now dramatically reduce the time taken for running Phase II studies. Synexus®, which is the world leader in recruiting and running late stage clinical trials, is able to do this by running the whole of a Phase II trial at its hubsites across the world.
